ConductScience.org, home

Paper766682

Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis.

Mitchell JR and 6 others. Ann Intern Med, 1976. Cited by 460 papers, by iCite.

Cite this record

ConductScience Library. Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis. Papers, record 766682. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/766682

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis.
PubMed
Journal
Ann Intern Med
PubMed
Year
1976
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
460
iCite
Relative citation ratio, by iCite
18.3
iCite
Revised in PubMed
2022-03-11
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mitchell JRJ R
2Zimmerman HJH J
3Ishak KGK G
4Thorgeirsson UPU P
5Timbrell JAJ A
6Snodgrass WRW R
7Nelson SDS D

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Chemical and Drug Induced Liver InjuryMajor topic
IsoniazidMajor topic
LiverMajor topic
Acetylation
Adult
Aged
Alanine Transaminase
Animals
Antibodies, Antinuclear
Aspartate Aminotransferases
Female
Humans
Hydrazines
Male
Middle Aged
Phenotype

Source PubMed

Download CSV of topics

Cited by119

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 460 citations.

PMIDTitleJournalYearIn PapersSource
42466481Validation of an UHPLC-MS/MS Assay for the Quantification of Isoniazid and Four Major Metabolites in Human Plasma.Biomed Chromatogr2026https://conductscience.org/library/papers/42466481PubMed
41323558Unraveling the Role of CYP2E1 in Antitubercular Drug-Induced Hepatotoxicity: From Molecular Mechanisms to Clinical Implications.Int J Hepatol2025https://conductscience.org/library/papers/41323558PubMed
40879696Deploying the drug repurposing approach for the identification of selective monoamine oxidase-B inhibitors against neurological disabilities: an in Silico and in vitro approach.J Comput Aided Mol Des2025https://conductscience.org/library/papers/40879696PubMed
40237651Hepatotoxicity Among People With HIV and Receiving Isoniazid Preventive Therapy in Pregnancy and Postpartum: The Role of Antiretroviral Regimen and Pharmacogenetics.Clin Infect Dis2026https://conductscience.org/library/papers/40237651PubMed
39959342Clinical perspectives of isoniazid-induced liver injury.Liver Res2021https://conductscience.org/library/papers/39959342PubMed
39364056Isoniazid-historical development, metabolism associated toxicity and a perspective on its pharmacological improvement.Front Pharmacol2024https://conductscience.org/library/papers/39364056PubMed
39165235Effect of chronic kidney disease on adverse drug reactions to anti-tubercular treatment: a retrospective cohort study.Ren Fail2024https://conductscience.org/library/papers/39165235PubMed
39085767Drug-induced hepatotoxicity and association with slow acetylation variants NAT2*5 and NAT2*6 in Cameroonian patients with tuberculosis and HIV co-infection.BMC Infect Dis2024https://conductscience.org/library/papers/39085767PubMed
38884784Polymorphism of CYP3A4*18 is associated with anti-tuberculosis drug-induced hepatotoxicity.Pharmacogenomics2024https://conductscience.org/library/papers/38884784PubMed
36500699Quantitative Analysis of Isoniazid and Its Four Primary Metabolites in Plasma of Tuberculosis Patients Using LC-MS/MS.Molecules2022https://conductscience.org/library/papers/36500699PubMed
36003040Pharmacokinetic and toxicodynamic concepts in idiosyncratic, drug-induced liver injury.Expert Opin Drug Metab Toxicol2022https://conductscience.org/library/papers/36003040PubMed
34872459Study on the associations between liver damage and antituberculosis drug rifampicin and relative metabolic enzyme gene polymorphisms.Bioengineered2021https://conductscience.org/library/papers/34872459PubMed
34545082Isonicotinylation is a histone mark induced by the anti-tuberculosis first-line drug isoniazid.Nat Commun2021https://conductscience.org/library/papers/34545082PubMed
33807700Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice.Antioxidants (Basel)2021https://conductscience.org/library/papers/33807700PubMed
33799477Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges.Int J Mol Sci2021https://conductscience.org/library/papers/33799477PubMed
33178178Etiopathogenesis, Challenges and Remedies Associated With Female Genital Tuberculosis: Potential Role of Nuclear Receptors.Front Immunol2020https://conductscience.org/library/papers/33178178PubMed
32735603Expression of type I collagen in response to Isoniazid exposure is indirect and is facilitated by collateral induction of cytochrome P450 2E1: An in-vitro study.PLoS One2020https://conductscience.org/library/papers/32735603PubMed
32550793Determination of isoniazid acetylation patterns in tuberculosis patients receiving DOT therapy under the Revised National tuberculosis Control Program (RNTCP) in India.Saudi Pharm J2020https://conductscience.org/library/papers/32550793PubMed
32373368Isoniazid and Rifampicin Produce Hepatic Fibrosis through an Oxidative Stress-Dependent Mechanism.Int J Hepatol2020https://conductscience.org/library/papers/32373368PubMed
32324077What have we learned from animal models of idiosyncratic, drug-induced liver injury?Expert Opin Drug Metab Toxicol2020https://conductscience.org/library/papers/32324077PubMed

See all 119 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/766682

GET https://conductscience.org/api/papers/v1/766682/cited_by?page=2